Alphabet Stock Surges on Gemini AI; Eli Lilly Slumps; RTX Defense Deal

Alphabet's Gemini AI Boosts Stock

• 🚀 Alphabet's stock saw a significant surge, its largest in two months, driven by positive reviews for its new Gemini artificial intelligence model.
• 💡 The company's AI offering, Gemini, is reported to have surpassed quality tests and benchmarks set by competitors like ChatGPT.
• 📈 This advancement in AI technology has led to a roughly 3% increase in Alphabet's Class C shares (GOOG), trading at $38.

Eli Lilly Faces Setback on Alzheimer's Trial Data

• 📉 Eli Lilly shares experienced a notable decline, down about 1.6%, trading at $1,042 (LLY ticker).
• ⚠️ This downturn follows news that competitor Novo Nordisk's Alzheimer's trial data did not show a statistically significant reduction in disease progression, impacting the broader Alzheimer's drug market.
• 🧐 Despite a price target upgrade from Bernstein, the stock's performance is being closely watched for potential recovery.

Healthcare Insurers Rally on Potential Policy Shifts

• 📈 Healthcare stocks, including United Health, Sigma, and Humana, are rallying amid reports of potential shifts in healthcare policy.
• 🏥 There is speculation about a possible two-year extension of Obamacare subsidies, which could positively impact the insurance sector.

Defense Stocks Face Pressure

• ⚠️ Defense stocks, such as Lockheed Martin (LMT) and RTX, are experiencing a downturn, down approximately 0.4% and 0.7% respectively.
• 🛡️ RTX and Israeli defense firm Rafael have secured a $1.25 billion contract to build surface-to-air missiles for Israel's Iron Dome system at a new plant in Arkansas.
• 🌍 The pressure on defense stocks appears to be influenced by trends in the European market, which is beginning to affect US-based companies as well.